Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus

Hydroxychloroquine (HCQ) and glucocorticoids (GCs) constitute the oldest and more used drugs in the treatment of systemic lupus erythematosus (SLE). Despite this long experience, both are still subject to a number of uncertainties, mainly regarding the dose.